1. |
|
2. |
|
3. |
|
4. |
|
5. |
Matonick JP, Hammond J. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model. J Invest Surg, 2014, 27(6): 360-365.
|
6. |
|
7. |
|
8. |
Schleckser P. The SURGICEL® powder mild or moderate parenchymal or soft tissue intraoperative bleeding (China study). 2018.
|
9. |
中华人民共和国国务院. 医疗器械监督管理条例. 2021.
|
10. |
国家药品监督管理局. 可吸收再生氧化纤维素止血颗粒获批上市. 2022.
|
11. |
|
12. |
|
13. |
|
14. |
|
15. |
|
16. |
|
17. |
NCT. The effect of arista on post-operative bleeding and wound drainage following mastectomy. 2018.
|
18. |
|
19. |
|
20. |
|
21. |
|
22. |
|
23. |
|
24. |
|
25. |
|
26. |
|
27. |
|
28. |
|
29. |
|
30. |
|
31. |
Björses K, Holst J. Topical haemostatics in renal trauma--an evaluation of four different substances in an experimental setting. J Trauma, 2009, 66(3): 602-611.
|
32. |
Ereth MH, Schaff M, Ericson EF, et al. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery, 2008, 63(4 Suppl 2): 369-372.
|
33. |
|
34. |
|
35. |
|
36. |
Shao H, Wu X, Xiao Y, et al. Recent research advances on polysaccharide-, peptide-, and protein-based hemostatic materials: a review. Int J Biol Macromol, 2024, 261(Pt 1): 129752.
|
37. |
Wolny Y, Tam T. Review of hemostatic agents used in robotic assisted laparoscopic gynecological surgeries. J Minim Invasive Gynecol, 2012, 19(6 Suppl 1): S167-S168.
|
38. |
|
39. |
|